Glucose Excipient Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Glucose Excipient Market size is expected to grow at an annual average CAGR of 3% during 2022-2028. Excipients play a huge role in drug formulation. An additive is a product included in a formulation to enhance or modify the therapeutic effect of a drug, not because of its action. By default, excipients are inert in nature. Glucose is also an important type of pharmaceutical excipient used in other formulations. Glucose acts as an excipient by the action of an osmotic agent, a binder, a sweetener, a base for syrup, and a parenteral agent. Addition of appropriate excipients improves patient compliance.

The following segmentation are covered in this report:

By Application

• Parenteral Nutrition
• Dialysis Applications
• Injectables

By Product

• Anhydrous Glucose
• Glucose Monohydrate

Company Profile

• Cargill, Inc
• ADM
• Tereos SA
• Roquette Freres S.A
• Ingredion Incorporated
• Archer Daniels Midland Company
• Avebe Group
• Tate and Lyle plc
• Feitian
• Lihua Starch

Scope of the report

The research study analyses the Glucose Excipient Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Glucose Excipient Market Report

• What was the Glucose Excipient Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Glucose Excipient Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.